Dermatologic Manifestations of COVID-19: A Comprehensive Systematic Review

    Fatima N. Mirza, Amyn A. Malik, Saad B. Omer, Aisha Sethi
    Image of study
    TLDR COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.
    The systematic review analyzed 86 studies involving 2,560 patients and found that the most common dermatologic manifestations of COVID-19 were chilblains/pernio-like lesions, erythematous maculopapular rashes, and viral exanthem. The latency from respiratory symptoms to skin findings was shorter in children than in adults, and a notable percentage of patients either were asymptomatic or had only skin manifestations. The review suggests that skin findings could be key for early COVID-19 detection. A case series from Italy highlighted a predominance of viral exanthem in male patients with a median age of 60, and an observational study in Spain suggested a link between severe COVID-19 and androgenetic alopecia in Caucasian males. The review emphasizes the importance of recognizing dermatologic signs as potential indicators of COVID-19, which could aid in managing the disease's spread.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    6 / 1000+ results

      community What else is good. Besides the big 3.

      in Chat  34 upvotes 2 months ago
      Key treatments for hair preservation include minoxidil, finasteride/dutasteride, and microneedling, with additional options like specific shampoos, oils, biotin, zinc, tretinoin, clascoterone, and low-level laser therapy. Maintaining a healthy lifestyle, reducing stress, and addressing nutrient deficiencies can also support hair health.

      community Homemade topical spironolactone

      in Research/Science  25 upvotes 2 years ago
      The potential effectiveness of homemade topical spironolactone in treating hair loss, with studies suggesting it is more effective than finasteride and even minoxidil when used as monotherapy. The conversation also mentions that other anti-androgens are being developed which may soon hit the market.

    Related Research

    1 / 1 results